Search

everythinglearnresearchcommunity

for

Search:↓

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Ashy dermatosis may be linked to atopy and thyroid disease and can be treated with topical steroids.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Saw palmetto causes allergic reaction, minoxidil causes skin irritation; use cautiously for hair loss.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Early treatment helps stop hair loss in women of color.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Niosomes are a promising and effective way to deliver drugs through the skin.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.

Antiandrogen therapy helps treat genetic hair loss.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.